withanolide d has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, S; Mandal, C; Mondal, S; Sangwan, R | 1 |
| Maity, R; Mallick, A; Mandal, C; Misra-Bhattacharya, S; Mondal, S; Roy, S; Sangwan, R | 1 |
1 review(s) available for withanolide d and Leucocythaemia
| Article | Year |
|---|---|
Withanolide D, carrying the baton of Indian rasayana herb as a lead candidate of antileukemic agent in modern medicine.
Topics: Adjuvants, Immunologic; Apoptosis; Ceramides; Herbal Medicine; Humans; Leukemia; Medicine, Ayurvedic; Withanolides | 2012 |
1 other study(ies) available for withanolide d and Leucocythaemia
| Article | Year |
|---|---|
Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Topics: Aniline Compounds; Apoptosis; Benzylidene Compounds; Blotting, Western; Cell Line, Tumor; Ceramides; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia; MAP Kinase Kinase 3; MAP Kinase Kinase 4; MAP Kinase Kinase 6; MAP Kinase Kinase 7; Microscopy, Electron, Scanning; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured; Withanolides | 2010 |